In summary, while epigenome-wide screens have highlighted PXDN, APBA2/APBA3, and MCF2 as tentative epigenetic markers in BPD, linking DNA methylation to early trauma exposure or clinical outcomes, these findings remain provisional. This evidence concerns the gene PXDN and Borderline personality disorder.